Home Healthcare Market

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Monitors, Nebulizers, BP Monitors), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication, Region - Global Forecast to 2025

Report Code: MD 1160 Oct, 2020, by marketsandmarkets.com

[253 Pages Report] The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period. Rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements of home care devices.

On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.

Home Healthcare Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 impact on the home healthcare market

The COVID-19 pandemic has a mixed impact on the home healthcare market. As the home healthcare market consists of products and services, both have different effects. COVID-19 would positively impact few home healthcare monitoring products such as blood glucose monitors, blood pressure monitors, pulse oximeters, and temperature monitors.

Due to the coronavirus pandemic, one might be under the assumption that the home healthcare service industry would be booming because home healthcare providers would be able to treat the vulnerable and elderly population in the comfort of their homes. However, the scenario is different. There have been many home healthcare agencies and providers who have reported a decline in the business.  However, this downturn in the home healthcare industry is predicted to be for a while, as the business will pick up at a faster pace in the coming future as more people are recovering from COVID-19.

Global Home Healthcare Market Dynamics

DRIVER: Rising aging population, high incidence of chronic diseases, and need to expand home healthcare access

The growth of the aging population segment will boost the demand for healthcare and significantly increase the burden on governments and health systems as the aging population is more prone to chronic diseases. This will prove favorable to the market for home healthcare, which can enhance the overall reach of and access to healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in traveling to meet healthcare professionals.

RESTRAINT: Patient safety concerns

In home care, the nurse-physician association involves lesser face-to-face contact, and the nurse is responsible for making assessments and communicating findings. This factor affects the degree of patient safety and outcomes. Another distinguishing characteristic of home healthcare is that clinicians offer medical care to each patient in a unique setting. However, there may be situational variables that present risks to patients that may be difficult to remove. Hospitals have well-equipped environmental safety departments to take care of such instances.

OPPORTUNITY: Untapped developing regions

Home healthcare is an established trend in the developed regions of North America and Europe. Due to favorable regulations and policies in these regions, homecare is rapidly being adopted. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific. As the concept of home healthcare in countries such as India and China is still in the early growth phase, market players can capitalize on a wide range of opportunities in these markets. For instance, in April 2017, Quadria Capital (Singapore) invested USD 40 million (INR 250 crore) in the Dabur family-owned HealthCare at Home (HCAH).

CHALLENGE: Shortage of home care workers

Home healthcare is a booming market, with increasing demand for home care providers/workers. According to the employment projections of the US Bureau of Labor Statistics, during 2014-2024, home healthcare occupations such as personal care aides and home health aides ranked among the top 10 in the list. Also, the demand for home health aides and personal care aides is estimated to be 2.9 million between 2016-2026. Hence, home healthcare providers need to find approximately 2.9 million heads to keep with the rising demand (Source: US Bureau of Labor Statistics).

The skilled nursing care services segment dominated the home healthcare services market in 2019.

Based on services, the global home healthcare market is segmented into rehabilitation services, infusion therapy services, unskilled care services, respiratory therapy services, pregnancy care services, skilled nursing services, and hospice and palliative care services. Skilled nursing services accounted for the largest share of the home healthcare services market in 2019. Skilled medical care in home settings can provide a comforting solution over residing in a hospital, nursing home, or an assisted living community. The favorable insurance coverage for skilled nursing services is expected to support the growth of this market during the forecast period.

The diabetes segment to witness the highest CAGR during the forecast period.

Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of diabetic patients. Monitoring blood sugar at home helps arrive at an overall diabetes treatment plan and aids in managing the medications for blood sugar, diet, and exercise.

Home Healthcare Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America was the largest regional market for home healthcare in 2019.

The home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The large share of North America in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and superior healthcare infrastructure.

Key Market Players

The prominent players operating in this market include Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Amedisys (US), Kindred at Home (US), and LHC Group, Inc. (US)

Scope of the report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

Product, service, indication, and region

Geographies covered

North America, Europe, Asia Pacific, and the Rest of the World

Companies covered

Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), A&D Company (Japan), BAYADA Home Health Care (US), Invacare Corporation (US), Abbott (US), Amedisys (US), Kindred at Home (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Drive DeVilbiss Healthcare (US), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd(China), Vitalograph (UK), advita Pflegedienst GmbH (Germany), RENAFAN GmbH (Germany), ADMR (France), Apex Medical Corporation (Taiwan), CONTEC MEDICAL SYSTEMS CO., LTD (China), and Lφwenstein Medical Technology GmbH + Co. KG. (Germany).

This report categorizes the home healthcare market into the following segments and subsegments

By Product

  • Testing, Screening, & Monitoring Products
    • Blood Glucose Monitors
    • Blood Pressure Monitors
    • Pulse Oximeters
    • Peak Flow Meters
    • Heart Rate Monitors
    • Fetal Monitoring Devices
    • HIV Test Kits
    • Home Sleep Testing Devices
    • Coagulation Monitoring Products
    • Ovulation and Pregnancy Test Kits
    • Holter and Event Monitors
    • Cholesterol Monitoring Devices
    • Colon Cancer Test Kits
    • Home Hemoglobin A1c Test Kits
    • Drug and Alcohol Test Kits
    • ECG/EKG Devices
    • EEG Devices
    • Temperature Monitors
    • Hearing Aids
    • Activity Monitors & Wristbands
  • Therapeutic Products
    • Oxygen Delivery Systems
    • Nebulizers
    • Ventilators
    • Sleep Apnea Therapeutic Devices
    • Wound Care Products
    • IV Equipment
    • Dialysis Equipment
    • Insulin Delivery Devices
    • Inhalers
    • Other Therapeutic Products (ostomy devices, automated external defibrillators (AEDs))
  • Mobility Care Products
    • Wheelchairs
    • Walkers & Rollators
    • Mobility Scooters
    • Canes
    • Crutches

By Service

  • Skilled Nursing Services
  • Rehabilitation Therapy Services
  • Hospice and Palliative Care Services
  • Unskilled Care Services
  • Respiratory Therapy Services
  • Infusion Therapy Services
  • Pregnancy Care Services

By Indication

  • Cardiovascular Disorders & Hypertension
  • Diabetes
  • Respiratory Diseases
  • Pregnancy
  • Mobility Disorders
  • Hearing Disorders
  • Cancer
  • Wound Care
  • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World

Recent Developments

  • In 2019, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition strengthens the company’s business in the US. It enables Fresenius Medical Care to leverage it's manufacturing, supply chain, and marketing competencies across the dialysis products, services, and care coordination businesses, especially in-home dialysis and critical care.
  • In 2020, Lincare, a subsidiary of Linde, offers home respiratory care in the US. In response to the COVID-19 pandemic, the company offers in-home services to COVID-19 vulnerable patients. It is also helping to ease the burden on hospitals by transferring respiratory patients and others from in-patient to in-home care.
  • LHC Group Inc (US) entered into a joint venture agreement with University Health Care System (US). This joint venture agreement was aimed to strengthen home health and hospice services across eight cities in Georgia and South Carolina.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 32)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
        FIGURE 1 HOME HEALTHCARE MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
        FIGURE 2 RESEARCH DESIGN
    2.2 SECONDARY DATA
           2.2.1 SECONDARY SOURCES
    2.3 PRIMARY DATA
           2.3.1 KEY DATA FROM PRIMARY SOURCES
                 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.4 MARKET SIZE ESTIMATION
           2.4.1 BOTTOM-UP APPROACH
                 FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.4.2 TOP-DOWN APPROACH
                 FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
           2.4.3 GROWTH FORECAST
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
        FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 42)
  FIGURE 7 HOME HEALTHCARE MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
  FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT, 2020 VS. 2025 (USD BILLION)
  FIGURE 9 HOME HEALTHCARE MARKET, BY SERVICE, 2020–2025 (USD BILLION)
  FIGURE 10 HOME HEALTHCARE MARKET, BY INDICATION, 2020 VS. 2025 (USD BILLION)
  FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL HOME HEALTHCARE MARKET

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 HOME HEALTHCARE MARKET OVERVIEW
        FIGURE 12 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
    4.2 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT AND COUNTRY (2019)
        FIGURE 13 WHEELCHAIRS DOMINATED THE MOBILITY CARE PRODUCTS MARKET IN ASIA PACIFIC IN 2019
    4.3 HOME HEALTHCARE MARKET, BY SERVICE, 2019
        FIGURE 14 INFUSION THERAPY SERVICES TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2020-2025)
    4.4 HOME HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT
        FIGURE 15 JAPAN TO REGISTER THE FASTEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 49)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 16 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Rising aging population, high incidence of chronic diseases, and need to expand healthcare access
                            TABLE 1 GLOBAL OVERVIEW OF THE RISE IN AGING POPULATION (MILLION)
                    5.2.1.2 Technological advancements
                    5.2.1.3 Increasing healthcare costs and the growing need for affordable treatment options
           5.2.2 RESTRAINTS
                    5.2.2.1 Changing reimbursement policies
                    5.2.2.2 Limited insurance coverage
                    5.2.2.3 Patient safety concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising focus on telehealth
                    5.2.3.2 Untapped developing regions
           5.2.4 CHALLENGES
                    5.2.4.1 Shortage of home care workers
           5.2.5 COVID-19 IMPACT
    5.3 PRICING ANALYSIS
    5.4 VALUE CHAIN ANALYSIS
        FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
    5.5 SUPPLY CHAIN ANALYSIS
        FIGURE 18 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.6 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET
        FIGURE 19 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET

6 HOME HEALTHCARE MARKET, BY PRODUCT (Page No. - 59)
    6.1 INTRODUCTION
        TABLE 2 HOME HEALTHCARE MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        TABLE 3 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
    6.2 THERAPEUTIC
        TABLE 4 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 5 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
           6.2.1 DIALYSIS EQUIPMENT
                    6.2.1.1 Dialysis equipment have gained significance due to their improved clinical outcomes and better quality of life for patients
                            TABLE 6 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.2 WOUND CARE PRODUCTS
                    6.2.2.1 Decreased cost and higher convenience and comfort of home care will ensure the growth of this segment
                            TABLE 7 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.3 IV EQUIPMENT
                    6.2.3.1 IV equipment facilitate the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy
                            TABLE 8 IV EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
                    6.2.4.1 Rising number of obstructive sleep apnea (OSA) cases and the growing prevalence of sleep disorders to drive the market for sleep apnea therapeutic devices
                            TABLE 9 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.5 INSULIN DELIVERY DEVICES
                    6.2.5.1 High incidence of diabetes to drive the insulin delivery devices market
                            TABLE 10 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.6 OXYGEN DELIVERY SYSTEMS
                    6.2.6.1 Technological advancements of oxygen therapy products to drive the market
                            TABLE 11 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.7 INHALERS
                    6.2.7.1 High incidence of asthma is the major factor driving the inhalers market
                            TABLE 12 INHALERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.8 NEBULIZERS
                    6.2.8.1 Nebulizers are more effective as compared to oral dosages
                            TABLE 13 NEBULIZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.9 VENTILATORS
                    6.2.9.1 Growing use of positive airway pressure devices for sleep apnea therapy is the key driver for the growth of the ventilators market in home care
                            TABLE 14 VENTILATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.2.10 OTHER THERAPEUTIC PRODUCTS
                  TABLE 15 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
    6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
        TABLE 16 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 17 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
           6.3.1 BLOOD GLUCOSE MONITORS
                    6.3.1.1 Increasing prevalence of diabetes to drive the market growth
                            TABLE 18 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.2 HEARING AIDS
                    6.3.2.1 High incidence of hearing impairment to drive the market
                            TABLE 19 HEARING AIDS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.3 BLOOD PRESSURE MONITORS
                    6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth
                            TABLE 20 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
                            TABLE 21 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
           6.3.4 ECG/EKG DEVICES
                    6.3.4.1 High prevalence of cardiovascular diseases to drive the market
                            TABLE 22 ECG/EKG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.5 OVULATION AND PREGNANCY TEST KITS
                    6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits
                            TABLE 23 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.6 PULSE OXIMETERS
                    6.3.6.1 Pulse oximeters are used to measure the oxygen saturation in the blood
                            TABLE 24 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                            TABLE 25 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
           6.3.7 HEART RATE MONITORS
                    6.3.7.1 Ability to continuously monitor the critical cardiac parameters to drive the demand for heart rate monitors
                            TABLE 26 HEART RATE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.8 COAGULATION MONITORING PRODUCTS
                    6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for the safe and effective management
                            TABLE 27 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.9 FETAL MONITORING DEVICES
                    6.3.9.1 High risk of preterm birth to drive the market for fetal monitoring devices
                            TABLE 28 FETAL MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.10 HIV TEST KITS
                    6.3.10.1 Rising prevalence of HIV to drive the market
                             TABLE 29 HIV TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.11 HOLTER AND EVENT MONITORS
                    6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market
                             TABLE 30 HOLTER AND EVENT MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.12 TEMPERATURE MONITORING DEVICES
                    6.3.12.1 Technological innovations and increasing awareness on the use of temperature monitoring devices for personal care to drive the growth of this market
                             TABLE 31 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.13 CHOLESTEROL TESTING PRODUCTS
                    6.3.13.1 Rising obesity levels and cardiovascular disorder incidence are the key factors supporting the market growth
                             TABLE 32 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.14 DRUG AND ALCOHOL TEST KITS
                    6.3.14.1 Consumption of drugs among teens supports the market growth
                             TABLE 33 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.15 PEAK FLOW METERS
                    6.3.15.1 Peak flow meters are used to monitor the person’s ability to breathe
                             TABLE 34 PEAK FLOW METERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.16 COLON CANCER TEST KITS
                    6.3.16.1 High incidence of colorectal cancer to support the market growth
                             TABLE 35 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.17 ACTIVITY MONITORS & WRIST BANDS
                    6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors
                             TABLE 36 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.18 EEG DEVICES
                    6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices
                             TABLE 37 EEG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.19 HOME SLEEP TESTING DEVICES
                    6.3.19.1 Cost-effectiveness of home-based sleep tests expected to fuel the growth of home sleep testing devices
                             TABLE 38 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.3.20 HOME HEMOGLOBIN A1C TEST KITS
                    6.3.20.1 High incidence of diabetes to drive the market
                             TABLE 39 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
    6.4 HOME HEALTHCARE MOBILITY CARE PRODUCTS
        TABLE 40 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 41 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
           6.4.1 WHEELCHAIRS
                    6.4.1.1 Increased preference for wheelchairs to support the market growth
                            TABLE 42 WHEELCHAIRS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.4.2 MOBILITY SCOOTERS
                    6.4.2.1 Mobility scooters help users to travel long distances
                            TABLE 43 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.4.3 WALKERS AND ROLLATORS
                    6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking
                            TABLE 44 WALKERS AND ROLLATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.4.4 CRUTCHES
                    6.4.4.1 Axilla crutches are the most preferred as they are easy to use and are often used by people who have a temporary injury
                            TABLE 45 CRUTCHES MARKET, BY REGION, 2018–2025 (USD MILLION)
           6.4.5 CANES
                    6.4.5.1 Canes are the most common assistive devices
                            TABLE 46 CANES MARKET, BY REGION, 2018–2025 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE (Page No. - 95)
    7.1 INTRODUCTION
        TABLE 47 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019
        TABLE 48 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD BILLION)
        TABLE 49 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.2 SKILLED NURSING
           7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD
                 TABLE 50 SKILLED NURSING SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.3 REHABILITATION THERAPY
           7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY
                 TABLE 51 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.4 HOSPICE AND PALLIATIVE CARE
           7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE AND PALLIATIVE CARE SERVICES
                 TABLE 52 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.5 UNSKILLED CARE
           7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER COMFORT AND SECURITY TO PATIENTS
                 TABLE 53 UNSKILLED CARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.6 RESPIRATORY THERAPY
           7.6.1 THE GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE THE MARKET
                 TABLE 54 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
    7.7 INFUSION THERAPY
           7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES
                 TABLE 55 INFUSION THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
    7.8 PREGNANCY CARE
           7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE HIGH-RISK PREGNANCIES AND COMPLICATIONS
                 TABLE 56 PREGNANCY CARE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION (Page No. - 104)
    8.1 INTRODUCTION
        TABLE 57 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
    8.2 CANCER
           8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE THE MARKET GROWTH
                 TABLE 58 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2018–2025 (USD BILLION)
    8.3 RESPIRATORY DISEASES
           8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO HAVE A POSITIVE IMPACT ON THIS SEGMENT
                 TABLE 59 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD BILLION)
    8.4 MOVEMENT/MOBILITY DISORDERS
           8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS
                 TABLE 60 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018–2025 (USD BILLION)
    8.5 CARDIOVASCULAR DISORDERS & HYPERTENSION
           8.5.1 RISING INCIDENCE OF HYPERTENSION AND CARDIOVASCULAR DISORDERS TO DRIVE THE GROWTH OF THIS SEGMENT
                 TABLE 61 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISORDERS & HYPERTENSION, BY REGION, 2018–2025 (USD BILLION)
    8.6 PREGNANCY
           8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE THE GROWTH OF THIS SEGMENT
                 TABLE 62 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2018–2025 (USD BILLION)
    8.7 WOUND CARE
           8.7.1 RISING PREVALENCE OF ROAD ACCIDENTS AND TRAUMA INJURIES DRIVE THE MARKET GROWTH
                 TABLE 63 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2018–2025 (USD BILLION)
    8.8 DIABETES
           8.8.1 INCREASING INCIDENCE OF DIABETES TO DRIVE THE GROWTH OF THIS MARKET
                 TABLE 64 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2018–2025 (USD BILLION)
    8.9 HEARING DISORDERS
           8.9.1 AGING IS ONE OF THE RISK FACTORS FOR HEARING DISORDERS
                 TABLE 65 GLOBAL INCIDENCE OF HEARING DISORDERS
                 TABLE 66 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2018–2025 (USD BILLION)
    8.10 OTHER INDICATIONS
         TABLE 67 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD BILLION)

9 HOME HEALTHCARE MARKET, BY REGION (Page No. - 113)
    9.1 INTRODUCTION
        TABLE 68 HOME HEALTHCARE MARKET, BY REGION, 2018–2025 (USD BILLION)
    9.2 NORTH AMERICA
        TABLE 69 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        FIGURE 20 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
        TABLE 70 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD BILLION)
        TABLE 71 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 72 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 73 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 74 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 75 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD BILLION)
        TABLE 76 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
           9.2.1 US
                    9.2.1.1 US to dominate the North American home healthcare market
                            TABLE 77 US: KEY INDICATORS
                            TABLE 78 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD BILLION)
                            TABLE 79 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 80 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 81 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 82 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 83 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 84 US: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising aging population drives the market in the country
                            TABLE 85 CANADA: KEY INDICATORS
                            TABLE 86 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 87 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 88 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 89 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 90 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 91 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 92 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
    9.3 EUROPE
        TABLE 93 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2018–2025 (USD BILLION)
        TABLE 94 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 95 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 96 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 97 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 98 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 99 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 100 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany to dominate the European Home Healthcare Market
                            TABLE 101 GERMANY: KEY INDICATORS
                            TABLE 102 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 103 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 104 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 105 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 106 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 107 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 108 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 Government support and initiatives taken by market players to drive the home healthcare market
                            TABLE 109 FRANCE: KEY INDICATORS
                            TABLE 110 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 111 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 112 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 113 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 114 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 115 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 116 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 High burden of chronic diseases to drive the market in the country
                            TABLE 117 UK: KEY INDICATORS
                            TABLE 118 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 119 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 120 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 121 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 122 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 123 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 124 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Rising geriatric population and the favorable government policy to drive the market in the country
                            TABLE 125 ITALY: KEY INDICATORS
                            TABLE 126 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 127 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 128 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 129 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 130 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 131 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 132 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increasing chronic conditions coupled with higher life expectancy to drive the market in the country
                            TABLE 133 SPAIN: KEY INDICATORS
                            TABLE 134 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 135 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 136 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 137 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 138 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 139 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 140 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.3.6 REST OF EUROPE
                    9.3.6.1 Growth in the target patient population to drive the market in the region
                            TABLE 141 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2016 (% OF GDP)
                            TABLE 142 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 143 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 144 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 145 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 146 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 147 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 148 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
    9.4 ASIA PACIFIC
        TABLE 149 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        FIGURE 21 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT
        TABLE 150 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 151 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 152 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 153 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 154 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 155 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 156 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Growing geriatric population in the country to drive the home healthcare market
                            TABLE 157 JAPAN: KEY INDICATORS
                            TABLE 158 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 159 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 160 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 161 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 162 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 163 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 164 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Healthcare development and reforms will drive the market in the country
                            TABLE 165 CHINA: KEY INDICATORS
                            TABLE 166 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2015–2022 (USD MILLION)
                            TABLE 167 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 168 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 169 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 170 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 171 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 172 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Increasing target patient population to drive the market in the country
                            TABLE 173 INDIA: KEY INDICATORS
                            TABLE 174 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 175 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 176 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 177 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 178 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 179 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                            TABLE 180 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                 TABLE 181 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 182 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 183 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 184 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 185 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 186 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE 187 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
    9.5 REST OF THE WORLD
        TABLE 188 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 189 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 190 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 191 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 192 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 193 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 194 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 184)
     10.1 OVERVIEW
          FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
          FIGURE 23 MARKET EVOLUTION FRAMEWORK
     10.2 MARKET SHARE ANALYSIS, 2019
          FIGURE 24 HOME BLOOD PRESSURE MONITORS MARKET SHARE, BY KEY PLAYER, 2019
          FIGURE 25 GLOBAL HEARING AID MARKET SHARE, BY KEY PLAYER, 2019
          FIGURE 26 HOME DIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2019
     10.3 COMPETITIVE SCENARIO
             10.3.1 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES (2017–2020)
             10.3.2 PRODUCT LAUNCHES & APPROVALS (2017-2020)
             10.3.3 EXPANSIONS (2017-2020)
             10.3.4 ACQUISITIONS (2017-2020)
     10.4 COMPANY EVALUATION QUADRANT (2020)
             10.4.1 VENDOR INCLUSION CRITERIA
             10.4.2 STAR
             10.4.3 EMERGING LEADERS
             10.4.4 PERVASIVE
             10.4.5 PARTICIPANT
                    FIGURE 27 MNM VENDOR DIVE COMPARISON MATRIX: HOME HEALTHCARE MARKET
     10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) FOR THE HOME HEALTHCARE SERVICES MARKET
             10.5.1 PROGRESSIVE COMPANIES
             10.5.2 STARTING BLOCKS
             10.5.3 RESPONSIVE COMPANIES
             10.5.4 DYNAMIC COMPANIES
                    FIGURE 28 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: HOME HEALTHCARE MARKET

11 COMPANY PROFILES (Page No. - 194)
(Business Overview, products & services offered, Recent Developments, MnM View)*
     11.1 FRESENIUS
          FIGURE 29 FRESENIUS: COMPANY SNAPSHOT (2019)
          TABLE 195 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EURO TO USD)
     11.2 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
          FIGURE 30 GENERAL ELECTRIC COMPANY SNAPSHOT: COMPANY SNAPSHOT (2019)
     11.3 LINDE PLC
          FIGURE 31 LINDE PLC: COMPANY SNAPSHOT (2019)
     11.4 ROCHE
          FIGURE 32 ROCHE: COMPANY SNAPSHOT (2019)
          TABLE 196 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF CHF TO USD)
     11.5 A&D COMPANY
          FIGURE 33 A&D COMPANY: COMPANY SNAPSHOT (2019)
          TABLE 197 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF JPY TO USD)
     11.6 BAYADA HOME HEALTH CARE
     11.7 INVACARE CORPORATION
          FIGURE 34 INVACARE CORPORATION: COMPANY SNAPSHOT (2019)
     11.8 ABBOTT LABORATORIES
          FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
     11.9 AMEDISYS
          FIGURE 36 AMEDISYS: COMPANY SNAPSHOT (2019)
     11.10 KINDRED AT HOME
     11.11 LHC GROUP
           FIGURE 37 LHC GROUP: COMPANY SNAPSHOT (2019)
     11.12 OMRON CORPORATION
           FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2019)
     11.13 KONINKLIJKE PHILIPS N.V.
           FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
     11.14 DRIVE DEVILBISS HEALTHCARE
     11.15 HAMILTON MEDICAL AG
*Details on Business Overview, products & services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
     11.16 SUNRISE MEDICAL
     11.17 ROMA MEDICAL
     11.18 CAREMAX REHABILITATION EQUIPMENT CO., LTD.
     11.19 VITALOGRAPH
     11.20 ADVITA PFLEGEDIENST GMBH
     11.21 RENAFAN GMBH
     11.22 ADMR
     11.23 APEX MEDICAL CORP.
     11.24 CONTEC MEDICAL SYSTEMS CO., LTD
     11.25 LΦWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.

12 APPENDIX (Page No. - 245)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the home healthcare market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the home healthcare market. The secondary sources used for this study include the World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), Home Care Association of America (HCAOA), Home Care Technology Association of America (HCTAA), American Telemedicine Association, American Heart Association, American Sleep Apnea Association (ASAA), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), United Kingdom Homecare Association (UKHCA), US Department of Veterans Affairs, The National Association for Home Care & Hospice, Alcohol & Drug Information Centre (ADIC), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Home Healthcare Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the home healthcare market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the home healthcare business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global home healthcare market based on the product, service, indication, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall home healthcare market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the home healthcare market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
COVID-19

Get in-depth analysis of the COVID-19 impact on the Home Healthcare Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Home Healthcare Market

Request For Special Pricing
Report Code
MD 1160
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Home Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home